Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DPR000023

Drug Information
NameBL-1020
Synonyms955400-87-0; BL 1020; Perphenazine 4-aminobutyrate; Butanoic acid, 4-amino-, 2-(4-(3-(2-chloro-10H-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester; BL-1020; 751477-01-7
CompanyBioLineRx
IndicationSchizophrenia
[ICD9: 295   ICD10: F20]
Phase II completed    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
CAS NumberCAS 1027512-25-9
PubChem Compound IDCID 44154447.
PubChem Substance IDSID 85150851.
ClinicalTrials.govNCT00480571;
TargetDopamine receptorAntagonist[1]
Dopamine receptorMultitarget[1]
Gamma-aminobutyric acid receptorAgonist[1]
Gamma-aminobutyric acid receptorMultitarget[1]
Ref 1The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543